Drug Trial Radar · NCT07587242
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
May 2029
Study completion Jul 2030
Sponsor
- Lead sponsor
- Avidity Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 7 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1044 for the treatment of Duchenne Muscular Dystrophy (DMD) with Gene Mutations Amenable to Exon 44 Skipping
Conditions
- Muscular Dystrophies
- Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)
- Muscular Disorders, Atrophic
- Muscular Disease
- Musculoskeletal Diseases
- Neuromuscular Diseases (NMD)
- Nervous System Diseases
- Genetic Diseases
- X-Linked
- Hereditary
- Neonatal Disease
- Duchene Muscular Dystrophy
- Congenital
- DMD
Interventions
AOC 1044Drug
AOC 1044 will be administered by intravenous (IV) infusion
PlaceboDrug
Placebo will be administered by intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Time to Rise (TTR) Velocity at Week 54Time frame: Baseline, Week 54
Locations
20 sites in 10 countries. Site status is shown where the registry gives one.
The Children's Hospital at Westmead
Westmead, New South Wales, Australia · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
Centre Hospitalier Régional de la Citadelle
Liège, Belgium · Recruiting
London Health Sciences Centre - Victoria Hospital
London, Ontario, Canada · Recruiting
CHU de Nantes - Hotel-Dieu
Nantes, France · Recruiting
AP-HP Hospital Armand-Trousseau
Paris, France · Recruiting
Universitaetsklinikum Essen
Essen, Germany · Recruiting
Universitaetsklinikum Heidelberg
Heidelberg, Germany · Recruiting
Klinikum der Ludwig-Maximilians-Universitaet Muenchen
München, Germany · Recruiting
Istituto Giannina Gaslini
Genova, Italy · Recruiting
Fondazione Serena ETS - Centro Clinico NeMO Milano
Milan, Italy · Recruiting
IRCCS Ospedale San Raffaele
Milan, Italy · Recruiting
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universitario Cattolica del Sacro Cuore
Roma, Italy · Recruiting
Academisch Ziekenhuis Leiden
Leiden, Netherlands · Recruiting
Uniwersyteckie Centrum Kliniczne, Gdańsk
Gdansk, Poland · Recruiting
Hospital Sant Joan de Deu
Barcelona, Spain · Recruiting
Hospital Universitario La Paz
Madrid, Spain · Recruiting
Hospital Viamed Santa Angela De la Cruz - FutureMeds Spain
Seville, Spain · Recruiting
Royal Victoria Infirmary
Newcastle, United Kingdom · Recruiting
University of Oxford and Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.